Does Ozempic actually cause muscle loss?

Yes, but less dramatically than the panic suggests. Trial data show people on semaglutide lose real lean mass, about 9.7 percent by week 68 in one sub-study, alongside a much bigger drop in fat. A 2024 JAMA review argues that ratio is normal for weight loss and not, by itself, a frailty risk for most people.

What the trial data actually show

The clearest numbers come from a DEXA sub-study of the STEP 1 trial, the same trial that got semaglutide approved as Wegovy, one of several GLP-1 drugs now compared head to head. Researchers scanned 140 participants' body composition at the start of treatment and again at week 68. People on semaglutide lost 15.0 percent of body weight, versus 3.6 percent on placebo. Fat mass fell by 19.3 percent, and lean mass, which includes muscle, organs and water, fell by 9.7 percent. Lean mass actually made up a slightly bigger share of total body weight by the end, simply because fat dropped faster than everything else.

Why a mouse study complicates the muscle story

A 2025 study in Cell Metabolism, run by researchers at the University of Utah, gave mice either a standard clinical dose of semaglutide or a much higher one, then tracked what shrank. Lean mass fell by about 10 percent, but most of that came from organs such as the liver, which lost close to half its mass, rather than from skeletal muscle. Some individual muscles shrank by roughly 6 percent on average, others stayed the same size, and a few lost measurable strength even when their size did not change. Senior author Katsu Funai, PhD, was candid about the limits: "Our findings are really interesting, but this is a preclinical model. We need these data in people."

Is this actually dangerous, or just arithmetic?

Here is where researchers split. A 2024 JAMA Viewpoint by Samuel Klein, MD, and colleagues argued that people with obesity usually start with more fat-free mass than leaner people, so losing a similar percentage of muscle during weight loss is less likely to leave them physically impaired. At a diabetes conference that December, Klein put it bluntly: "The concern that marked weight loss induced by GLP-1-based therapy can cause physical frailty and sarcopenia is not supported by any data."

Not everyone treats that as settled. Richard Pratley, MD, of AdventHealth Diabetes Institute, responded that "we are accelerating this loss of muscle mass with GLP-1 treatments" and that for older patients specifically, "we have to balance the weight loss and all of those positive benefits against decreases in function." He pointed out that clinical trial populations tend to be younger and healthier than the people actually prescribed these drugs today, which is part of why he urged caution rather than blanket reassurance.

Who should actually worry

The risk is not evenly spread. People most likely to lose meaningful strength, not just lean tissue on a scan, are older adults, women, anyone starting the drug with already-low muscle mass, and anyone whose appetite drops so much that protein intake falls with it. Low physical activity during treatment makes the loss worse. None of this is unique to semaglutide. Rapid weight loss from any method, including bariatric surgery or severe calorie restriction, pulls some muscle down along with the fat; GLP-1 drugs just made the question urgent because so many more people are losing weight this fast, this suddenly.

What actually protects muscle while losing weight

The advice is consistent across endocrinologists, dietitians and bariatric specialists even when the exact numbers vary slightly. Registered dietitian Michelle Routhenstein says adequate protein and resistance training "work together to stimulate muscle protein synthesis" during weight loss. Clinicians interviewed by Healthline suggested roughly 1.2 to 1.5 grams of protein per kilogram of body weight a day, paired with resistance training two to three times a week. The baseline guidance on how much protein you need a day still applies here, it is just harder to hit when a medication is actively suppressing appetite, which is exactly why some people on these drugs track protein deliberately instead of assuming it will sort itself out.

Our take

The headline fear, that Ozempic quietly dissolves your muscle, overstates what the data actually show. Most of what people lose on these drugs is fat, and the lean mass that comes off with it is roughly proportionate to how much weight disappears overall. But "roughly proportionate" is not the same as "irrelevant," particularly if you are older, already have little muscle to spare, or barely eating enough to notice you're not getting protein. Treat strength training and protein as part of the prescription, not an afterthought, and ask whoever prescribes the drug to track your strength alongside your weight.

This is general information, not medical advice. Talk to a clinician before changing anything, especially if you are pregnant, nursing, or managing a condition.